The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic

A growing body of evidence initially suggested that patients with multiple sclerosis (MS) might be more susceptible to coronavirus disease 2019 (COVID-19). Moreover, it was speculated that patients with MS treated with immunosuppressive drugs might be at risk to develop a severe diseases course afte...

Descripción completa

Detalles Bibliográficos

Autores principales:	Maryam Azimzadeh, Nora Möhn, Sajjad Ghane Ezabadi, Zahra Moghimi Esfandabadi, Alireza Soleimani, Elaheh Ranjbar, Maliheh Jahromi, Reihaneh Seyedebrahimi, Thomas Skripuletz, Farshad Moharrami Kasmaie
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2021-09-01
Colección:	Biomolecules
Materias:	multiple sclerosis (MS) COVID-19 disease-modifying therapies (DMTs)
Acceso en línea:	https://www.mdpi.com/2218-273X/11/9/1372
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!